共 112 条
[1]
ANDERSEN M J, FLORES-MIRELES A L., Urinary Catheter Coating Modifications: The Race against Catheter-Associated Infections, Coatings, 10, 1, (2020)
[2]
DAVOODIAN P, NEMATEE M, SHEIKHVATAN M., Inappropriate Use of Urinary Catheters and Its Common Complications in Different Hospital Wards, Saudi Journal of Kidney Diseases and Transplantation, 23, 1, pp. 63-67, (2012)
[3]
TRAUTNER B W, HULL R A, THORNBY J I, Et al., Coating Urinary Catheters with an Avirulent Strain of Escherichia Coli as a Means to Establish Asymptomatic Colonization, Infection Control and Hospital Epidemiology, 28, 1, pp. 92-94, (2007)
[4]
DAROUICHE R O, MANSOURI M D, GAWANDE P V, Et al., Efficacy of Combination of Chlorhexidine and Protamine Sulphate Against Device-Associated Pathogens, The Journal of Antimicrobial Chemotherapy, 61, 3, pp. 651-657, (2008)
[5]
LIU L, SHI H C, YU H, Et al., The Recent Advances in Surface Antibacterial Strategies for Biomedical Catheters, Biomaterials Science, 8, 15, pp. 4095-4108, (2020)
[6]
TENKE P, MEZEI T, BODE I, Et al., Catheter-Associated Urinary Tract Infections, European Urology Supplements, 16, 4, pp. 138-143, (2017)
[7]
BHATIA N, DAGA M K, GARG S, Et al., Urinary Catheterization in Medical Wards, Journal of Global Infectious Diseases, 2, 2, pp. 83-90, (2010)
[8]
EDWARDS J R, PETERSON K D, ANDRUS M L, Et al., National Healthcare Safety Network (NHSN) Report, Data Summary for 2006, Issued June 2007, American Journal of Infection Control, 35, 5, pp. 290-301, (2007)
[9]
GILBERT R, BROWN M, RAINFORD N, Et al., Antimicrobial-Impregnated Central Venous Catheters for Prevention of Neonatal Bloodstream Infection (PREVAIL): An Open-Label, Parallel-Group, Pragmatic, Randomised Controlled Trial, The Lancet Child & Adolescent Health, 3, 6, pp. 381-390, (2019)
[10]
VOELKER R., Updated Guidelines Target Reductions in Catheter-Related Bloodstream Infections, JAMA, 305, 17, pp. 1753-1754, (2011)